Which cardiovascular risk factors matter in chronic kidney disease?

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 9-11

  Baigent, Colin ^a   Landray, Martin ^a  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

Author keywords

Blood pressure; Cholesterol; Epidemiology; Haematocrit; Randomized trials; Risk factors

Indexed keywords

ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; DIALYSIS; DISEASE ASSOCIATION; HEART INFARCTION; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; NOTE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT PLANNING;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS; RISK; RISK FACTORS;

EID: 33846004810     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl580     Document Type: Note

References (20)

1. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35: S117-S131
2. Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
3. Corti M-C, Garalnik JM, Salive ME et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997; 126: 753-760
4. Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Cardiac Fail 2002; 8: 216-224
5. Chao FC, Efron B, Wolf P. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy. Cancer 1975; 35: 1223-1229
6. Neaton JD, Wentworth DN. Low serum cholesterol and risk of death from AIDS. AIDS 1997; 11: 929-930
7. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic haemodialysis. Nephron 1982; 31: 103-110
8. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
9. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152
10. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of cholesterol-lowering treatment: Prospective metaanalysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278
11. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
12. US Renal Data System. Annual Data Report: Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005
13. Baigent C, Landray MJ. Study of Heart and Renal Protection (SHARP). Kidney Int 2003; 63 [Suppl 84]: S207-S210
14. Fellstrom B, Zannad F, Schmieder R et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study. Curr Control Trials Cardiovasc Med 2005; 6: 9
15. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
16. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: A new preventive strategy. Health Technol Assess 2003; 7: 1-94
17. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-745
18. Laposata M. The New England Journal of Medicine SI Unit Conversion Guide. Boston, MA: 1992
19. Danesh J, Collins R, Peto R, Lowe GDO. Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000; 21: 515-520
20. Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61